Literature DB >> 22910543

Reduced T helper and B lymphocytes in Parkinson's disease.

Claire H Stevens1, Dominic Rowe, Marie-Christine Morel-Kopp, Carolyn Orr, Tonia Russell, Madelaine Ranola, Christopher Ward, Glenda M Halliday.   

Abstract

Gene association with HLA suggests involvement of immune mediated mechanisms in the pathogenesis of Parkinson's disease (PD). Only a small number of studies have found differences between circulating leukocyte populations in PD patients compared to controls, with conflicting results. To clarify whether there is a circulating leukocyte PD phenotype, we assessed the numbers of T, B and natural killer cells, and monocytes and found a small reduction (15-25%) in CD4+ T and CD19+ B cells in PD. These findings suggest some compromise in immune cells in PD and have potential implications for immune function and the progression of PD.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22910543     DOI: 10.1016/j.jneuroim.2012.07.015

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  72 in total

1.  Clinical characteristics and peripheral T cell subsets in Parkinson's disease patients with constipation.

Authors:  Yuhua Chen; Meiling Yu; Xiaolin Liu; Hongdang Qu; Qiming Chen; Weidong Qian; Daoxiang Wei; Wenfang Xu; Bo Ma; Wei Wu
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

Review 2.  The correlation of lymphocyte subsets, natural killer cell, and Parkinson's disease: a meta-analysis.

Authors:  Sen Jiang; Hua Gao; Qin Luo; Pengfei Wang; Xinling Yang
Journal:  Neurol Sci       Date:  2017-05-11       Impact factor: 3.307

Review 3.  Immune system responses in Parkinson's disease: Early and dynamic.

Authors:  Malú G Tansey; Marina Romero-Ramos
Journal:  Eur J Neurosci       Date:  2018-12-10       Impact factor: 3.386

4.  A critical role for alpha-synuclein in development and function of T lymphocytes.

Authors:  Afshin Shameli; Wenbin Xiao; Yan Zheng; Susan Shyu; John Sumodi; Howard J Meyerson; Clifford V Harding; Robert W Maitta
Journal:  Immunobiology       Date:  2015-10-20       Impact factor: 3.144

Review 5.  Vaccination strategies for Parkinson disease: induction of a swift attack or raising tolerance?

Authors:  Marina Romero-Ramos; Marianne von Euler Chelpin; Vanesa Sanchez-Guajardo
Journal:  Hum Vaccin Immunother       Date:  2014-03-26       Impact factor: 3.452

Review 6.  Role of α-synuclein in inducing innate and adaptive immunity in Parkinson disease.

Authors:  Heather E Allen Reish; David G Standaert
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

7.  Alterations of p11 in brain tissue and peripheral blood leukocytes in Parkinson's disease.

Authors:  Holly Green; Xiaoqun Zhang; Katarina Tiklova; Nikolaos Volakakis; Lovisa Brodin; Louise Berg; Paul Greengard; Thomas Perlmann; Per Svenningsson
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-30       Impact factor: 11.205

8.  Peripheral Lymphocyte Subsets as a Marker of Parkinson's Disease in a Chinese Population.

Authors:  Luan Cen; Chaohao Yang; Shuxuan Huang; Miaomiao Zhou; Xiaolu Tang; Kaiping Li; Wenyuan Guo; Zhuohua Wu; Mingshu Mo; Yousheng Xiao; Xiang Chen; Xinling Yang; Qinhui Huang; Chaojun Chen; Shaogang Qu; Pingyi Xu
Journal:  Neurosci Bull       Date:  2017-08-08       Impact factor: 5.203

9.  Reduced Activated T Lymphocytes (CD4+CD25+) and Plasma Levels of Cytokines in Parkinson's Disease.

Authors:  Natalia Pessoa Rocha; Frankcinéia Assis; Paula Luciana Scalzo; Érica Leandro Marciano Vieira; Izabela Guimarães Barbosa; Mariana Soares de Souza; Paulo Pereira Christo; Helton José Reis; Antonio Lucio Teixeira
Journal:  Mol Neurobiol       Date:  2017-02-07       Impact factor: 5.590

Review 10.  The dopamine transporter: An unrecognized nexus for dysfunctional peripheral immunity and signaling in Parkinson's Disease.

Authors:  Phillip Mackie; Joe Lebowitz; Leila Saadatpour; Emily Nickoloff; Peter Gaskill; Habibeh Khoshbouei
Journal:  Brain Behav Immun       Date:  2018-03-15       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.